Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

491 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Uterine ultrasonographic changes with gonadotropin-releasing hormone agonists.
Weeks AD, Duffy SR, Walker JJ. Weeks AD, et al. Am J Obstet Gynecol. 1999 Jan;180(1 Pt 1):8-13. doi: 10.1016/s0002-9378(99)70140-7. Am J Obstet Gynecol. 1999. PMID: 9914569 Clinical Trial.
OBJECTIVES: Our purpose was to assess the changes in uterine volume and uterine artery pulsatility index in response to gonadotropin-releasing hormone agonist treatment in women undergoing hysterectomy for nonfibroid-related uterine bleeding. STUDY DESIGN: A double-blind, …
OBJECTIVES: Our purpose was to assess the changes in uterine volume and uterine artery pulsatility index in response to gonadotropin-releasi …
Decreasing estrogen in nonpregnant women lowers uterine myometrial type I nitric oxide synthase protein expression.
Weeks AD, Massmann AG, Monaghan JM, Crowther D, Duffy SR, Walker JJ, Figueroa JP. Weeks AD, et al. Am J Obstet Gynecol. 1999 Jul;181(1):25-30. doi: 10.1016/s0002-9378(99)70430-8. Am J Obstet Gynecol. 1999. PMID: 10411788 Clinical Trial.
STUDY DESIGN: Twenty-four women were randomly assigned to treatment with gonadotropin-releasing hormone agonist or placebo for 8 weeks before hysterectomy, at which time samples of myometrium were collected and the serum levels of estrogen, nitrate, and nitrite measured. . …
STUDY DESIGN: Twenty-four women were randomly assigned to treatment with gonadotropin-releasing hormone agonist or placebo for 8 weeks
A randomized trial of misoprostol compared with manual vacuum aspiration for incomplete abortion.
Weeks A, Alia G, Blum J, Winikoff B, Ekwaru P, Durocher J, Mirembe F. Weeks A, et al. Obstet Gynecol. 2005 Sep;106(3):540-7. doi: 10.1097/01.AOG.0000173799.82687.dc. Obstet Gynecol. 2005. PMID: 16135584 Clinical Trial.
OBJECTIVE: To compare the safety, efficacy, and acceptability of misoprostol and manual vacuum aspiration for the treatment of incomplete abortion in a hospital setting in Kampala, Uganda. METHODS: Three hundred seventeen women with clinically diagnosed incomplete first-tr …
OBJECTIVE: To compare the safety, efficacy, and acceptability of misoprostol and manual vacuum aspiration for the treatment of incomplete ab …
The Release Trial: a randomised controlled trial of umbilical vein oxytocin versus placebo for the treatment of retained placenta.
Weeks A, Mirembe F, Alfirevic Z. Weeks A, et al. BJOG. 2005 Oct;112(10):1458. doi: 10.1111/j.1471-0528.2005.00681.x. BJOG. 2005. PMID: 16167963 Clinical Trial.
ENTRY CRITERIA: The women recruited will be stable haemodynamically, not bleeding vaginally, over 34 weeks of gestation and with a retained placenta for at least 30 minutes. ...
ENTRY CRITERIA: The women recruited will be stable haemodynamically, not bleeding vaginally, over 34 weeks of gestation and with a
Oral misoprostol for induction of labour.
Alfirevic Z, Weeks A. Alfirevic Z, et al. Among authors: weeks a. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD001338. doi: 10.1002/14651858.CD001338.pub2. Cochrane Database Syst Rev. 2006. PMID: 16625542 Updated. Review.
Misoprostol for induction of labor with a live fetus.
Weeks A, Alfirevic Z, Faúndes A, Hofmeyr GJ, Safar P, Wing D. Weeks A, et al. Int J Gynaecol Obstet. 2007 Dec;99 Suppl 2:S194-7. doi: 10.1016/j.ijgo.2007.09.011. Epub 2007 Oct 25. Int J Gynaecol Obstet. 2007. PMID: 17961564
Treatment of postpartum hemorrhage with misoprostol.
Blum J, Alfirevic Z, Walraven G, Weeks A, Winikoff B. Blum J, et al. Among authors: weeks a. Int J Gynaecol Obstet. 2007 Dec;99 Suppl 2:S202-5. doi: 10.1016/j.ijgo.2007.09.013. Epub 2007 Oct 24. Int J Gynaecol Obstet. 2007. PMID: 17961565 Review.
491 results